全球医用大妈行业市场前景及投资研究报告-培训课件外文版2024.5加拿大美国

INDUSTRIES

&

MARKETSTherapeutic

Cannabis:

marketdata

&

analysisMarket

InsightsreportAugust

2023MARKET

INSIGHTSThis

report

is

part

ofour

Market

Insights

productGainabetterunderstandingofmarketsacross190+

geographicalentities

–

onaglobal,

regional,country,

and/orstatelevel.

Accessourdatavia

webinterface,download(XLS,

PDF,PPT),or

reports.Benefitfromour48-hourcustomerservice

guarantee.•

10

sectors:

advertising&media,consumers,countries,digital

sector,finance,health,

industrialsector,mobility,andtechnology•

1,000+

markets,

e.g.,

FinTech,Food,or

Robotics•

KPIs,

e.g.,

revenue,marketshares,prices,andvolume•

Features:Compare

countries®ions,

change

currencies,

selectvisualizations,

and/or

customize

downloads•

Usecases:

sales

planning,

investment

decision

support,resourceallocation,andportfolio

management10sectors190+geographicalentities1,000+markets400+reportsFind

out

more

on:https://www.Goto

Market

Insightscom/outlook/3CHAPTER

1OverviewThe

Therapeutic

Cannabis

market

covers

all

sales

from

lowertetrahydrocannabinol

(THC)

levels

cannabidiol

(CBD)Overview:

Management

SummarySummaryTherapeutic

Cannabis

products

aregainingmainstream

prominence,

especiallyaftertheoutbreak

of

theCOVID-19

pandemic,owing

to

factorssuchas

growingstress

and

anxiety

levels,

and

thesubsequent

need

forconsumers

toreceive

aid.These

products

which

canbeconsumed

asoils,pills,and

edibles,

among

otherforms,

arereadily

availableinmost

nationsthroughouttheworld,

unlikeRecreational

Cannabis

products,which

areheavily

regulated

andarelegally

soldinonly

ahandful

ofcountries.Theindustryisalsowitnessing

much

innovationinterms

of

new

productdevelopment,

emergence

ofnew

startups,androbustM&A

activity,which

webelieve

will

also

bekey

drivingfactorsmoving

forwardin

thismarket.

Forinstance,theUnited

Statesbasedmanufacturer,CheefBotanicals,

hasrecently

launchedVegan

CBDGummies,

inAugust

2022,

inorder

toattractdiet-consciousconsumers.

Moreover,

manymanufacturers

arealsolooking

atexploringsyntheticbiology

tools

formanufacturingCBD

products,which

would

result

inlower

manufacturing

costs

and

ultimately,higherprofits,andisexpected

to

beakey

trend

inthemanufacturingof

theseproducts.It'sinteresting

tonotethatthese

productsare

notonly

meant

forhumanuse,butforanimals

aswell.

A2020

survey

ofover

5,000

pet

owners

conducted

byresearch

firmAttestandProhibition

Partnersrevealed

thatnearly

75%

of

themhadpurchasedCBD

products

fortheirdogs.

Thegrowing

petpopulation,therefore

isexpected

to

beone

ofthekey

drivingfactorsinthisspace,inthemedium

to

long

term.5Sources:Market

Insights

2023Therapeutic

Cannabis

is

an

important

part

of

the

Cannabis

MarketOverview:

Market

DefinitionMarket

DefinitionTheTherapeutic

Cannabismarket

covers

cannabinoid-based

therapeuticproductswith

low

tetrahydrocannabinol

(THC)levels.

These

products

areused

formedicinalpurposes

andareintended

to

improve

thequality

of

life,e.g.,byreducing

stressand/oranxiety.

Prescribed

andnon-prescribed

products

are

includedinourscopeandcanbeconsumed

through

oils,capsules,topicals,e-liquid,

edibles,

and

flowers.6Sources:Market

Insights

2023Therapeutic

Cannabis

accounted

for

27.31%

of

the

Cannabis

market

revenue

in2022Overview:

Market

DefinitionKeyTakeawaysInscopeOutof

scopeRevenue

intheTherapeutic

Cannabismarket

is

projected

to

reach

US$14.42bn

in2023.Thismarket

includes:Thismarket

excludes:Revenue

is

expected

toshow

anannualgrowth

rate(CAGR

(1)

2023-2028)

of15.48%,resulting

inamarket

volume

of

US$29.61bn

by2028.•Extracts•Highertetrahydrocannabinol

(THC)levels

ofcannabidiol(CBD)•Dried

cannabis•EdiblesInglobalcomparison,

most

revenue

will

begenerated

intheUnitedStates(US$3,944.00m

in2023).•Medical

cannabis•Recreational

cannabisInrelation

to

totalpopulation

figures,per

person

revenues

of

US$24.47

aregenerated

in2023.•Beverages7Notes:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Sources:CHAPTER

2Market

NumbersTherapeutic

Cannabis

revenue

is

estimated

to

increase

at

a

CAGR(1)

of

26.2%from2016

to

2028Market

Size:

GlobalRevenue

forecast

inbillionUS$29.626.423.320.2+26.2%(1)17.214.411.48.76.34.73.42.41.820162017201820192020202120222023202420252026202720289Notes:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023Sources:With

a

revenue

of

US$

5.3

billion,

Europe

is

the

biggest

market

among

selectedregions

in

2022Market

Size:

Regional

Comparison

(1/2)Revenue

forecast

inbillionUS$+18.0%(1)14.3+16.2%(1)11.15.3+18.4%(1)+18.4%(1)4.50.0%(1)2.11.70.80.60.10.12022202820222028202220282022202820222027EuropeAfricaAmericasAsiaAustralia10

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023With

a

revenue

of

3.3

billion

US$,

the

United

States

are

the

biggest

marketamong

selected

countries,

in

2022Market

Size:

Regional

Comparison

(2/2)Revenue

forecast

inbillionUS$+15.7%(1)7.9+15.7%(1)+18.0%(1)3.3+15.8%(1)+18.1%(1)2.31.51.00.920280.720280.60.40.320222028202220282022202820222022United

StatesNetherlandsGermanyCanadaMalta11

Notes:Sources:(1)

CAGR:

Compound

Annual

GrowthRateMarket

Insights

2023The

average

revenue

per

user

in

the

Therapeutic

Cannabis

market

is

estimatedto

decrease

from2016

to

2028Market

Size:

GlobalAveragerevenue

peruserforecast

inUS$54.653.055504540353025201510543.533.729.728.628.027.326.125.525.124.523.30201620172018201920202021202220232024202520262027202812Sources:Market

Insights

2023Europe

has

the

biggest

market

in

Therapeutic

Cannabis

in

terms

of

averagerevenue

per

userin

2022Market

Size:

GlobalAveragerevenue

peruserforecast

inUS$1101009080706050403020100102.858.995.259.492.959.991.080.087.560.587.777.583.974.682.863.580.271.477.168.574.865.969.560.163.461.12016201720182019202020212022202320242025202620272028EuropeUnited

States13Sources:Market

Insights

2023With

an

average

revenue

per

user

of

515.7

US$,

the

Netherlands

are

the

biggestmarket

among

selected

countries,

in

2022Market

Size:

GlobalAveragerevenue

peruserforecast

inUS$7006005004003002001000649.8628.6603.4578.6555.7534.7515.7500.9498.3497.0489.9493.3492.7110.2103.799.2106.598.993.589.692.395.488.384.887.279.50.0102.02026102.82027106.0202894.197.987.190.580.681.181.279.582.92016201720182019202020212022202320242025NetherlandsCanadaGermany14Sources:Market

Insights

2023Therapeutic

Cannabis

users

are

estimated

to

increase

from

2016

to

2028Market

Size:

GlobalUsersforecast

inmillions995.81,000900800700600500400300200924.3852.9774.1686.7589.2446.22022372.82021225.62020139.2201977.645.9100

33.1020162017201820232024202520262027202815Sources:Market

Insights

2023There

are

more

users

of

Therapeutic

Cannabis

in

the

United

States

than

inEurope

in

2022Market

Size:

GlobalUsersforecast

inmillions157.398.9160145.991.2134.583.514012010080122.075.7108.367.892.959.964.251.862.043.76039.935.44028.722.923.314.718.99.415.36.12002016201720182019202020212022202320242025202620272028EuropeUnited

States16Sources:Market

Insights

2023With

51.8

million

users,

the

United

States

are

the

biggest

market

amongselected

countries,

in

2022Market

Size:

GlobalUsersforecast

inmillions98.910091.2908070605040302010083.575.767.814.959.912.751.810.243.77.435.44.228.72.316.918.520.023.30.221.514.518.913.48.212.215.30.06.610.94.93.19.62.01.20.020160.0

0.720172018201920202021United

States2022202320242025202620272028United

KingdomGermany17Sources:Market

Insights

2023Most

male

consumers

in

the

United

States

take

cannabis/CBD

to

reduce

pain,whilst

most

females

use

it

to

reduceanxietyConsumer

Insights:United

StatesReasons

oftakingcannabis(1)20%20%19%18%18%17%17%16%15%

15%9%7%7%6%5%5%4%3%2%2%2%

2%OtherReduce

painReduceanxietyRelaxationandstressreliefSleep

aidReducedepressionImproveheart

health

cancer-relatedsymptomsAlleviateSubstanceabusetreatmentReduce

skinproblemsTreatmentof

epilepsyMalesFemales18

Notes:Sources:(1):

“Forwhich

ofthese

benefits

do

ordid

youuse

medical

cannabis

/CBD?”;(multi-pick);

U.S.:

n=2,049,

males;n=999,

females;n=1,050Consumer

Insights

2023Just

like

the

United

States,

most

male

consumers

in

the

United

Kingdom

takecannabis/CBD

to

reduce

pain,

whilst

most

females

use

it

to

reduce

anxietyConsumer

Insights:United

KingdomReasons

oftakingcannabis(1)10%10%9%9%8%8%8%

8%7%5%5%4%4%3%3%3%2%2%2%2%1%1%Reduce

painSleep

aidReduceanxietyReducedepressionRelaxationandstressreliefReduce

skinproblemsImproveheart

healthTreatmentof

epilepsy

cancer-relatedsymptomsAlleviateSubstanceabusetreatmentOtherMalesFemales19

Notes:Sources:(1):

“Forwhich

ofthese

benefits

do

ordid

youuse

medical

cannabis

/CBD?”;(multi-pick);

UK:n=2,087,

males;n=1,023,

females;

n=1,064Consumer

Insights

2023InGermany,

most

male

consumers

take

cannabis/CBD

to

reduce

depression,whilst

most

females

use

it

to

reducepainConsumer

Insights:GermanyReasons

oftakingcannabis(1)6%6%5%5%

5%5%4%4%3%3%3%2%2%2%

2%2%2%1%1%1%1%

1%OtherReducedepressionReduce

painSleep

aidRelaxationandstressreliefReduceanxietyImproveheart

healthTreatmentof

epilepsyReduce

skinproblemsSubstanceabusetreatmentAlleviatecancer-relatedsymptomsMalesFemales20

Notes:Sources:(1):

“Forwhich

ofthese

benefits

do

ordid

youuse

medical

cannabis

/CBD?”;(multi-pick);

Germany:n=2,071,

males;n=1,093,

females;

n=978Consumer

Insights

2023CHAPTER

3AppendixMARKET

INSIGHTSMarket

Insights

–

market

data,forecasts,

and

qualitative

insightsGainabetterunderstandingofmarketsacross190+

geographicalentities

–

onaglobal,

regional,country,

and/orstatelevel.

Accessourdatavia

webinterface,download(XLS,

PDF,PPT),or

reports.Benefitfromour48-hourcustomerservice

guarantee.•

10

sectors:

advertising&media,consumers,countries,digital